PDB Short entry for 2B50 HEADER GENE REGULATION 27-SEP-05 2B50 TITLE HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 205-476; COMPND 5 SYNONYM: PPAR-DELTA, PPAR- BETA, NUCLEAR HORMONE RECEPTOR 1, NUC1, COMPND 6 NUCI; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 GOLD (DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-15B KEYWDS NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, GENE REGULATION EXPDTA X-RAY DIFFRACTION AUTHOR S.A.FYFFE,M.S.ALPHEY,L.BUETOW,T.K.SMITH,M.A.J.FERGUSON,M.D.SORENSEN, AUTHOR 2 F.BJORKLING,W.N.HUNTER REVDAT 4 13-MAR-24 2B50 1 HETSYN REVDAT 3 29-JUL-20 2B50 1 COMPND REMARK SEQADV HETNAM REVDAT 3 2 1 LINK SITE REVDAT 2 24-FEB-09 2B50 1 VERSN REVDAT 1 14-FEB-06 2B50 0 JRNL AUTH S.A.FYFFE,M.S.ALPHEY,L.BUETOW,T.K.SMITH,M.A.J.FERGUSON, JRNL AUTH 2 M.D.SORENSEN,F.BJORKLING,W.N.HUNTER JRNL TITL RECOMBINANT HUMAN PPAR-BETA/DELTA LIGAND-BINDING DOMAIN IS JRNL TITL 2 LOCKED IN AN ACTIVATED CONFORMATION BY ENDOGENOUS FATTY JRNL TITL 3 ACIDS JRNL REF J.MOL.BIOL. V. 356 1005 2006 JRNL REFN ISSN 0022-2836 JRNL PMID 16405912 JRNL DOI 10.1016/J.JMB.2005.12.047 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 94.49 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 3 NUMBER OF REFLECTIONS : 44692 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2251 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 REFLECTION IN BIN (WORKING SET) : 3081 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.40 REMARK 3 BIN R VALUE (WORKING SET) : 0.2840 REMARK 3 BIN FREE R VALUE SET COUNT : 163 REMARK 3 BIN FREE R VALUE : 0.3510 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4198 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 80 REMARK 3 SOLVENT ATOMS : 519 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.49 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.03000 REMARK 3 B22 (A**2) : 2.09000 REMARK 3 B33 (A**2) : -1.91000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.60000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.183 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.172 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.134 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.901 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.921 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4364 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5881 ; 1.329 ; 1.979 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 519 ; 5.313 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 189 ;34.279 ;24.074 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 780 ;17.047 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;21.133 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 676 ; 0.097 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3172 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2103 ; 0.208 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2974 ; 0.299 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 411 ; 0.157 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 5 ; 0.163 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 119 ; 0.315 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 51 ; 0.316 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): 2 ; 0.143 ; 0.200 REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2706 ; 0.672 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4237 ; 1.123 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1845 ; 1.622 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1644 ; 2.630 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2B50 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 29-SEP-05. REMARK 100 THE DEPOSITION ID IS D_1000034682. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 65 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.939261 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5% PEG 8000, 200MM KCL, 40MM BIS-TRIS REMARK 280 -PROPANE PH 8.5, 2.5% 1,2-PROPANEDIOL, 0.5% N-HEPTYL-B-D- REMARK 280 GLUCOPYRANOSIDE, 1MM EDTA, 10MM DTT, VAPOUR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 46.04200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A MONOMER. THERE ARE 2 BIOLOGICAL REMARK 300 UNITS THE AYMMETRIC UNIT (CHAINS A AND B) REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 205 REMARK 465 PRO A 206 REMARK 465 GLN A 207 REMARK 465 VAL A 208 REMARK 465 ALA A 209 REMARK 465 ASP A 210 REMARK 465 GLN A 266 REMARK 465 LEU A 267 REMARK 465 VAL A 268 REMARK 465 ASN A 269 REMARK 465 GLY A 270 REMARK 465 LYS B 240 REMARK 465 ALA B 241 REMARK 465 SER B 242 REMARK 465 GLN B 266 REMARK 465 LEU B 267 REMARK 465 VAL B 268 REMARK 465 ASN B 269 REMARK 465 GLY B 270 REMARK 465 MET B 476 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 240 CB CG CD CE NZ REMARK 470 ALA A 241 CB REMARK 470 SER A 242 CB OG REMARK 470 GLN A 429 CG CD OE1 NE2 REMARK 470 GLU A 462 CG CD OE1 OE2 REMARK 470 GLN B 429 CG CD OE1 NE2 REMARK 470 GLU B 462 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 2397 O HOH B 2609 2.10 REMARK 500 CG2 ILE B 363 O HOH B 2545 2.11 REMARK 500 OD1 ASP B 383 O HOH B 2417 2.15 REMARK 500 O GLN B 451 O HOH B 2376 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 CD PRO A 359 O HOH B 2481 2656 1.83 REMARK 500 O HOH A 1351 O HOH B 2459 2656 1.83 REMARK 500 CD PRO B 359 O HOH B 2368 1655 1.84 REMARK 500 O HOH A 1436 O HOH B 2343 2656 1.93 REMARK 500 O HOH A 1340 O HOH B 2599 2656 2.03 REMARK 500 N LEU A 211 O HOH B 2576 2555 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 263 -54.36 -131.27 REMARK 500 MET A 401 -61.70 -91.01 REMARK 500 GLN A 430 1.65 85.28 REMARK 500 GLU A 460 73.22 -104.96 REMARK 500 ASP A 475 -5.48 83.99 REMARK 500 LYS B 260 27.57 -72.28 REMARK 500 GLU B 460 67.31 -107.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A1303 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 407 OE2 REMARK 620 2 GLN A 410 OE1 90.0 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B2303 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU B 407 OE2 REMARK 620 2 GLN B 410 OE1 87.1 REMARK 620 3 HOH B2428 O 76.2 90.6 REMARK 620 4 HOH B2578 O 79.6 91.4 155.6 REMARK 620 N 1 2 3 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2AWH RELATED DB: PDB REMARK 900 2AWH REPRESENTS THE SAME PROTEIN AND LIGAND AS THE ONE WHICH IS REMARK 900 BEING DEPOSITED. THE PROTEIN IN 2AWH WAS DERIVED FROM A COMMERCIAL REMARK 900 SOURCE AND THE DATA WHICH IS BEING DEPOSITED WAS FROM AN IN-HOUSE REMARK 900 EXPRESSION SYSTEM. BOTH STRUCTRES COMPRISE UNIQUE UNIT CELL REMARK 900 DIMENSIONS. DBREF 2B50 A 205 476 UNP Q03181 PPAS_HUMAN 169 440 DBREF 2B50 B 205 476 UNP Q03181 PPAS_HUMAN 169 440 SEQADV 2B50 GLN A 430 UNP Q03181 TYR 394 CONFLICT SEQADV 2B50 GLN B 430 UNP Q03181 TYR 394 CONFLICT SEQRES 1 A 272 ASN PRO GLN VAL ALA ASP LEU LYS ALA PHE SER LYS HIS SEQRES 2 A 272 ILE TYR ASN ALA TYR LEU LYS ASN PHE ASN MET THR LYS SEQRES 3 A 272 LYS LYS ALA ARG SER ILE LEU THR GLY LYS ALA SER HIS SEQRES 4 A 272 THR ALA PRO PHE VAL ILE HIS ASP ILE GLU THR LEU TRP SEQRES 5 A 272 GLN ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL ASN SEQRES 6 A 272 GLY LEU PRO PRO TYR LYS GLU ILE SER VAL HIS VAL PHE SEQRES 7 A 272 TYR ARG CYS GLN CYS THR THR VAL GLU THR VAL ARG GLU SEQRES 8 A 272 LEU THR GLU PHE ALA LYS SER ILE PRO SER PHE SER SER SEQRES 9 A 272 LEU PHE LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY SEQRES 10 A 272 VAL HIS GLU ALA ILE PHE ALA MET LEU ALA SER ILE VAL SEQRES 11 A 272 ASN LYS ASP GLY LEU LEU VAL ALA ASN GLY SER GLY PHE SEQRES 12 A 272 VAL THR ARG GLU PHE LEU ARG SER LEU ARG LYS PRO PHE SEQRES 13 A 272 SER ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL LYS SEQRES 14 A 272 PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA LEU SEQRES 15 A 272 PHE ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO GLY SEQRES 16 A 272 LEU MET ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP THR SEQRES 17 A 272 ILE LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN HIS SEQRES 18 A 272 PRO ASP ALA GLN GLN LEU PHE PRO LYS LEU LEU GLN LYS SEQRES 19 A 272 MET ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN SEQRES 20 A 272 MET MET GLN ARG ILE LYS LYS THR GLU THR GLU THR SER SEQRES 21 A 272 LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP MET SEQRES 1 B 272 ASN PRO GLN VAL ALA ASP LEU LYS ALA PHE SER LYS HIS SEQRES 2 B 272 ILE TYR ASN ALA TYR LEU LYS ASN PHE ASN MET THR LYS SEQRES 3 B 272 LYS LYS ALA ARG SER ILE LEU THR GLY LYS ALA SER HIS SEQRES 4 B 272 THR ALA PRO PHE VAL ILE HIS ASP ILE GLU THR LEU TRP SEQRES 5 B 272 GLN ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL ASN SEQRES 6 B 272 GLY LEU PRO PRO TYR LYS GLU ILE SER VAL HIS VAL PHE SEQRES 7 B 272 TYR ARG CYS GLN CYS THR THR VAL GLU THR VAL ARG GLU SEQRES 8 B 272 LEU THR GLU PHE ALA LYS SER ILE PRO SER PHE SER SER SEQRES 9 B 272 LEU PHE LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY SEQRES 10 B 272 VAL HIS GLU ALA ILE PHE ALA MET LEU ALA SER ILE VAL SEQRES 11 B 272 ASN LYS ASP GLY LEU LEU VAL ALA ASN GLY SER GLY PHE SEQRES 12 B 272 VAL THR ARG GLU PHE LEU ARG SER LEU ARG LYS PRO PHE SEQRES 13 B 272 SER ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL LYS SEQRES 14 B 272 PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA LEU SEQRES 15 B 272 PHE ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO GLY SEQRES 16 B 272 LEU MET ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP THR SEQRES 17 B 272 ILE LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN HIS SEQRES 18 B 272 PRO ASP ALA GLN GLN LEU PHE PRO LYS LEU LEU GLN LYS SEQRES 19 B 272 MET ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN SEQRES 20 B 272 MET MET GLN ARG ILE LYS LYS THR GLU THR GLU THR SER SEQRES 21 B 272 LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP MET HET CA A1303 1 HET B7G A 920 19 HET B7G A 921 19 HET VCA A1001 20 HET CA B2303 1 HET VCA B2001 20 HETNAM CA CALCIUM ION HETNAM B7G HEPTYL BETA-D-GLUCOPYRANOSIDE HETNAM VCA VACCENIC ACID HETSYN B7G HEPTYL-BETA-D-GLUCOPYRANOSIDE; HEPTYL BETA-D-GLUCOSIDE; HETSYN 2 B7G HEPTYL D-GLUCOSIDE; HEPTYL GLUCOSIDE HETSYN VCA (11E)-OCTADEC-11-ENOIC ACID FORMUL 3 CA 2(CA 2+) FORMUL 4 B7G 2(C13 H26 O6) FORMUL 6 VCA 2(C18 H34 O2) FORMUL 9 HOH *519(H2 O) HELIX 1 1 LEU A 211 PHE A 226 1 16 HELIX 2 2 THR A 229 THR A 238 1 10 HELIX 3 3 ASP A 251 GLY A 261 1 11 HELIX 4 4 GLU A 276 SER A 302 1 27 HELIX 5 5 ILE A 303 LEU A 309 1 7 HELIX 6 6 PHE A 310 ALA A 331 1 22 HELIX 7 7 ALA A 342 GLY A 344 5 3 HELIX 8 8 ARG A 350 LEU A 356 1 7 HELIX 9 9 ARG A 357 ALA A 376 1 20 HELIX 10 10 ASP A 380 LEU A 393 1 14 HELIX 11 11 ASN A 402 HIS A 425 1 24 HELIX 12 12 GLN A 430 GLU A 460 1 31 HELIX 13 13 HIS A 466 LYS A 474 1 9 HELIX 14 14 ASN B 205 PHE B 226 1 22 HELIX 15 15 THR B 229 GLY B 239 1 11 HELIX 16 16 ASP B 251 LYS B 260 1 10 HELIX 17 17 GLU B 276 SER B 302 1 27 HELIX 18 18 ILE B 303 SER B 308 1 6 HELIX 19 19 PHE B 310 ALA B 331 1 22 HELIX 20 20 ARG B 350 SER B 355 1 6 HELIX 21 21 ARG B 357 ALA B 376 1 20 HELIX 22 22 ASP B 380 LEU B 393 1 14 HELIX 23 23 ASN B 402 HIS B 425 1 24 HELIX 24 24 GLN B 430 GLU B 460 1 31 HELIX 25 25 HIS B 466 LYS B 474 1 9 SHEET 1 A 4 PHE A 247 ILE A 249 0 SHEET 2 A 4 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 A 4 GLY A 338 VAL A 341 -1 N LEU A 339 O VAL A 348 SHEET 4 A 4 VAL A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 SHEET 1 B 4 PHE B 247 ILE B 249 0 SHEET 2 B 4 GLY B 346 THR B 349 1 O PHE B 347 N ILE B 249 SHEET 3 B 4 GLY B 338 VAL B 341 -1 N VAL B 341 O GLY B 346 SHEET 4 B 4 VAL B 334 ASN B 335 -1 N ASN B 335 O GLY B 338 LINK OE2 GLU A 407 CA CA A1303 1555 1555 2.31 LINK OE1 GLN A 410 CA CA A1303 1555 1555 2.39 LINK OE2 GLU B 407 CA CA B2303 1555 1555 2.34 LINK OE1 GLN B 410 CA CA B2303 1555 1555 2.39 LINK CA CA B2303 O HOH B2428 1555 1555 2.59 LINK CA CA B2303 O HOH B2578 1555 1555 2.09 CRYST1 39.776 92.084 95.017 90.00 97.00 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025140 0.000000 0.003090 0.00000 SCALE2 0.000000 0.010860 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010600 0.00000